Trial Outcomes & Findings for Exercise Regulation of Human Adipose Tissue (NCT NCT03133156)

NCT ID: NCT03133156

Last Updated: 2025-08-14

Results Overview

Body fat percentage measured before and after exercise training with a bioelectrical impedance scale.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

93 participants

Primary outcome timeframe

Baseline measurement (week 0, prior to starting exercise training) and post-intervention measurement at week 10, after completion of exercise training.

Results posted on

2025-08-14

Participant Flow

Participant milestones

Participant milestones
Measure
Moderate Intensity Training-Healthy Lean
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Healthy Overweight/Obese
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
Eligible subjects will undergo a 10-week moderate intensity exercise program.
High Intensity Training-Healthy Lean
Eligible subjects will undergo a 10-week high intensity exercise program
Overall Study
STARTED
35
35
11
12
Overall Study
COMPLETED
26
28
10
10
Overall Study
NOT COMPLETED
9
7
1
2

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

"Body fat percentage data unavailable due to recording error."

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Moderate Intensity Training-Healthy Lean
n=35 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program. Exercise Intervention: 10-Week Aerobic Exercise Training
Moderate Intensity Training-Healthy Overweight/Obese
n=35 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program. Exercise Intervention: 10-Week Aerobic Exercise Training
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
n=11 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program. Exercise Intervention: 10-Week Aerobic Exercise Training
High Intensity Training-Healthy Lean.
n=12 Participants
Eligible subjects will undergo a 10-week high intensity exercise program Exercise Intervention: 10-Week Aerobic Exercise Training
Total
n=93 Participants
Total of all reporting groups
Age, Continuous
36 years
STANDARD_DEVIATION 8 • n=35 Participants
38.9 years
STANDARD_DEVIATION 8.5 • n=35 Participants
49.6 years
STANDARD_DEVIATION 5.1 • n=11 Participants
36.9 years
STANDARD_DEVIATION 9.7 • n=12 Participants
38.8 years
STANDARD_DEVIATION 9 • n=93 Participants
Sex: Female, Male
Female
15 Participants
n=35 Participants
19 Participants
n=35 Participants
8 Participants
n=11 Participants
6 Participants
n=12 Participants
48 Participants
n=93 Participants
Sex: Female, Male
Male
20 Participants
n=35 Participants
16 Participants
n=35 Participants
3 Participants
n=11 Participants
6 Participants
n=12 Participants
45 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=35 Participants
4 Participants
n=35 Participants
0 Participants
n=11 Participants
2 Participants
n=12 Participants
11 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
28 Participants
n=35 Participants
27 Participants
n=35 Participants
10 Participants
n=11 Participants
6 Participants
n=12 Participants
71 Participants
n=93 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=35 Participants
4 Participants
n=35 Participants
1 Participants
n=11 Participants
4 Participants
n=12 Participants
11 Participants
n=93 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=35 Participants
0 Participants
n=35 Participants
0 Participants
n=11 Participants
0 Participants
n=12 Participants
0 Participants
n=93 Participants
Race (NIH/OMB)
Asian
10 Participants
n=35 Participants
5 Participants
n=35 Participants
1 Participants
n=11 Participants
4 Participants
n=12 Participants
20 Participants
n=93 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=35 Participants
0 Participants
n=35 Participants
0 Participants
n=11 Participants
0 Participants
n=12 Participants
0 Participants
n=93 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=35 Participants
1 Participants
n=35 Participants
1 Participants
n=11 Participants
0 Participants
n=12 Participants
3 Participants
n=93 Participants
Race (NIH/OMB)
White
21 Participants
n=35 Participants
28 Participants
n=35 Participants
8 Participants
n=11 Participants
8 Participants
n=12 Participants
65 Participants
n=93 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=35 Participants
0 Participants
n=35 Participants
1 Participants
n=11 Participants
0 Participants
n=12 Participants
1 Participants
n=93 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants
n=35 Participants
1 Participants
n=35 Participants
0 Participants
n=11 Participants
0 Participants
n=12 Participants
4 Participants
n=93 Participants
Region of Enrollment
United States
35 participants
n=35 Participants
35 participants
n=35 Participants
11 participants
n=11 Participants
12 participants
n=12 Participants
93 participants
n=93 Participants
Body Fat Percentage (via Bioelectrical Impedance Analysis
24.49 Body Fat %
STANDARD_DEVIATION 6.65 • n=34 Participants • "Body fat percentage data unavailable due to recording error."
35.04 Body Fat %
STANDARD_DEVIATION 7.69 • n=35 Participants • "Body fat percentage data unavailable due to recording error."
38.42 Body Fat %
STANDARD_DEVIATION 6.71 • n=11 Participants • "Body fat percentage data unavailable due to recording error."
26.60 Body Fat %
STANDARD_DEVIATION 7.71 • n=12 Participants • "Body fat percentage data unavailable due to recording error."
30.44 Body Fat %
STANDARD_DEVIATION 9 • n=92 Participants • "Body fat percentage data unavailable due to recording error."
Bodyweight
70.21 kilograms
STANDARD_DEVIATION 8.81 • n=35 Participants
88.04 kilograms
STANDARD_DEVIATION 11.89 • n=35 Participants
83.01 kilograms
STANDARD_DEVIATION 8.42 • n=11 Participants
73.03 kilograms
STANDARD_DEVIATION 11.19 • n=12 Participants
78.8 kilograms
STANDARD_DEVIATION 13 • n=93 Participants
Body Fat Mass
24.49 kilograms
STANDARD_DEVIATION 6.65 • n=34 Participants • Body fat mass data unavailable due to a recording error.
30.75 kilograms
STANDARD_DEVIATION 7.94 • n=35 Participants • Body fat mass data unavailable due to a recording error.
32.01 kilograms
STANDARD_DEVIATION 6.74 • n=11 Participants • Body fat mass data unavailable due to a recording error.
19.31 kilograms
STANDARD_DEVIATION 5.38 • n=12 Participants • Body fat mass data unavailable due to a recording error.
24.4 kilograms
STANDARD_DEVIATION 9.2 • n=92 Participants • Body fat mass data unavailable due to a recording error.

PRIMARY outcome

Timeframe: Baseline measurement (week 0, prior to starting exercise training) and post-intervention measurement at week 10, after completion of exercise training.

Body fat percentage measured before and after exercise training with a bioelectrical impedance scale.

Outcome measures

Outcome measures
Measure
Moderate Intensity Training-Healthy Lean
n=26 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Healthy Overweight/Obese
n=28 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
n=10 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
High Intensity Training-Healthy Lean
n=10 Participants
Eligible subjects will undergo a 10-week high intensity exercise program
Changes in Human Adipose Tissue Characteristics Following Exercise Training
pre-training
25.45 body fat %
Standard Deviation 6.34
34.12 body fat %
Standard Deviation 7.97
38.06 body fat %
Standard Deviation 6.96
27.05 body fat %
Standard Deviation 7.70
Changes in Human Adipose Tissue Characteristics Following Exercise Training
post-training
25.38 body fat %
Standard Deviation 7.02
33.90 body fat %
Standard Deviation 8.60
37.20 body fat %
Standard Deviation 7.31
25.32 body fat %
Standard Deviation 7.57

PRIMARY outcome

Timeframe: Baseline measurement (week 0, prior to starting exercise training) and post-intervention measurement at week 10, after completion of exercise training.

Body fat mass measured before and after exercise training with a bioelectrical impedance scale.

Outcome measures

Outcome measures
Measure
Moderate Intensity Training-Healthy Lean
n=26 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Healthy Overweight/Obese
n=28 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
n=10 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
High Intensity Training-Healthy Lean
n=10 Participants
Eligible subjects will undergo a 10-week high intensity exercise program
Changes in Human Adipose Tissue Characteristics Following Exercise Training
pre-training
17.83 kilograms
Standard Deviation 4.38
29.96 kilograms
Standard Deviation 7.55
31.47 kilograms
Standard Deviation 6.85
19.76 kilograms
Standard Deviation 5.54
Changes in Human Adipose Tissue Characteristics Following Exercise Training
post-training
17.69 kilograms
Standard Deviation 4.72
29.61 kilograms
Standard Deviation 8.22
30.61 kilograms
Standard Deviation 7.23
18.11 kilograms
Standard Deviation 5.81

PRIMARY outcome

Timeframe: Baseline measurement (week 0, prior to starting exercise training) and post-intervention measurement at week 10, after completion of exercise training.

Body weight measured before and after exercise training with a bioelectrical impedance scale.

Outcome measures

Outcome measures
Measure
Moderate Intensity Training-Healthy Lean
n=26 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Healthy Overweight/Obese
n=28 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
n=10 Participants
Eligible subjects will undergo a 10-week moderate intensity exercise program.
High Intensity Training-Healthy Lean
n=10 Participants
Eligible subjects will undergo a 10-week high intensity exercise program
Changes in Human Adipose Tissue Characteristics Following Exercise Training
pre-training
70.55 kilograms
Standard Deviation 8.99
88.22 kilograms
Standard Deviation 10.47
82.4 kilograms
Standard Deviation 8.62
73.27 kilograms
Standard Deviation 12.07
Changes in Human Adipose Tissue Characteristics Following Exercise Training
post-training
70.4 kilograms
Standard Deviation 8.67
87.59 kilograms
Standard Deviation 10.8
81.90 kilograms
Standard Deviation 8.97
71.81 kilograms
Standard Deviation 12.78

Adverse Events

Moderate Intensity Training-Healthy Lean

Serious events: 0 serious events
Other events: 2 other events
Deaths: 0 deaths

Moderate Intensity Training-Healthy Overweight/Obese

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Moderate Intensity Training-Overweight/Obese Type 2 Diabetes

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

High Intensity Training-Healthy Lean

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Moderate Intensity Training-Healthy Lean
n=35 participants at risk
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Healthy Overweight/Obese
n=35 participants at risk
Eligible subjects will undergo a 10-week moderate intensity exercise program.
Moderate Intensity Training-Overweight/Obese Type 2 Diabetes
n=11 participants at risk
Eligible subjects will undergo a 10-week moderate intensity exercise program.
High Intensity Training-Healthy Lean
n=12 participants at risk
Eligible subjects will undergo a 10-week high intensity exercise program
Musculoskeletal and connective tissue disorders
Back Pain
2.9%
1/35 • 16 weeks
0.00%
0/35 • 16 weeks
0.00%
0/11 • 16 weeks
8.3%
1/12 • 16 weeks
Musculoskeletal and connective tissue disorders
Knee Pain
2.9%
1/35 • 16 weeks
0.00%
0/35 • 16 weeks
0.00%
0/11 • 16 weeks
0.00%
0/12 • 16 weeks
Musculoskeletal and connective tissue disorders
Ankle Pain
2.9%
1/35 • 16 weeks
0.00%
0/35 • 16 weeks
0.00%
0/11 • 16 weeks
0.00%
0/12 • 16 weeks
Musculoskeletal and connective tissue disorders
Muscle Cramp
0.00%
0/35 • 16 weeks
0.00%
0/35 • 16 weeks
9.1%
1/11 • 16 weeks
0.00%
0/12 • 16 weeks
Nervous system disorders
Parethesia
0.00%
0/35 • 16 weeks
2.9%
1/35 • 16 weeks
0.00%
0/11 • 16 weeks
0.00%
0/12 • 16 weeks
Cardiac disorders
Chest Discomfort
2.9%
1/35 • 16 weeks
0.00%
0/35 • 16 weeks
0.00%
0/11 • 16 weeks
0.00%
0/12 • 16 weeks
Nervous system disorders
Lightheadedness
0.00%
0/35 • 16 weeks
0.00%
0/35 • 16 weeks
9.1%
1/11 • 16 weeks
0.00%
0/12 • 16 weeks
Injury, poisoning and procedural complications
Toe Injury
0.00%
0/35 • 16 weeks
2.9%
1/35 • 16 weeks
0.00%
0/11 • 16 weeks
0.00%
0/12 • 16 weeks

Additional Information

Laura Simpson

Joslin Diabetes Center

Phone: 617-735-3924

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place